WuXi XDC Cayman Inc
2268
Rangering i aksjer
#1886
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Aksjekurs
$8.78
Markedsverdi
$11.12B
Endring (1 dag)
-9.52%
Endring (1 år)
0.57%
Land
CN
Handel WuXi XDC Cayman Inc (2268)
Kategori
Healthcare
Historikk for aksjesplitt for WuXi XDC Cayman Inc (2268)
Aksjen WuXi XDC Cayman Inc (symbol: 2268) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én 2268-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 2268-aksjer.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én 2268-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 2268-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 3 | x2 |
CN
|
|
| 1 | x1 |
US
|
